Doctors often cite the high price of a prescription drug as a reason they don’t prescribe it, while patients similarly say that cost is a main reason they quit taking a drug.
Removing this financial barrier might increase the use of evidence-based therapies, improve patient adherence to those medications, and potentially save lives. That theory was tested in a study of heart attack survivors led by the Duke Clinical Research Institute; findings were presented March 11 at the American College of …